SB1324 Summary

• Limits new opioid prescriptions to 90 morphine milligram equivalents (MME) per day for patients outside healthcare institutions, with certain exceptions.

• Exempts continuations of prior prescriptions, opioids with FDA-approved maximum daily doses, post-surgical prescriptions (limited to 14 days), and patients with cancer, traumatic injury, hospice/end-of-life care, palliative care, skilled nursing facility care, burns, medication-assisted treatment, or hospitalization.

• Requires health professionals to consult with a pain-certified physician or a designated opioid assistance referral service before prescribing over 90 MME per day (unless the prescriber is board-certified in pain), with exceptions if the consulting physician is unavailable within 48 hours.

• Mandates prescribing naloxone hydrochloride or another FDA-approved opioid antagonist to patients receiving more than 90 MME per day, except those receiving hospice or end-of-life care.

• Exempts pharmacists from verifying prescription compliance with MME limits; prescriptions meeting exemption requirements are automatically deemed compliant.